A new study led by the University of Miami Miller School of Medicine's Kirill Martemyanov, Ph.D., and international ...

Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...

Smoking, higher body mass index (BMI), and previous exposure to biologics were linked to poorer responses to biologics among patients with psoriasis, in a meta-analysis. Older age (odds ratio [OR], ...

Biologic treatment costs for plaque psoriasis more than doubled from 2007 to 2021, despite cheaper alternatives. Switching to the lowest-cost biologic in each class could reduce treatment costs by 44% ...

Please provide your email address to receive an email when new articles are posted on . Practices receive biologics directly and then bill the payer for their use. Advantages include improved ...

A 46-year-old man presents for his first dermatology consultation for worsening symptoms of plaque psoriasis and recent-onset joint pain. He reports “painful aching” and swelling of his finger joints, ...

Please provide your email address to receive an email when new articles are posted on . To overcome barriers to biologic care for patients with asthma, personalized treatment is key, according to a ...

Eczema can be managed with certain self-care regimens, such as fragrance-free soap, brief lukewarm baths or showers, and regular skin hydration with a strong emollient like CeraVe cream or Vaseline.

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...

Two studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate, but these did not select for poor prognosis. The aim, therefore, of the SPEED trial ...